Gemcitabine Plus Albumin-bound Paclitaxel In Patients With Advanced Metastatic Pancreatic Cancer

Outcome

Outcome unknown

Phase

Phase 1 / Phase 2

Status

Completed

Study type

Interventional

Start

1 November 2006

Expected end

1 December 2010

Enrollment

67 participants

Sites

5

Primary outcomes

Number of Participants With Dose-limiting Toxicities

Sponsor

Industry

Results posted

2013-08-21

Last update

22 November 2019

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.